recall
saveLannett Company Inc. recall (Cls II)
October 29, 2025updated 5mo ago
community read0 votes
Niacin Extended-release Tablets, USP, 1,000 mg, Rx Only, 90 Tablets per bottle, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC: 62175-322-46 — Reason: Failed Dissolution Specifications — Status: Ongoing
view source ↗Data sources
last refreshed just now
Found something off?
same company · ±60 days · 6
- approvalMETADATE ER: METADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalOct 2, 2025
- approvalMETADATE ER: METADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalOct 2, 2025
- approvalacetaminophen ER: HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalDec 8, 2025
- approvalacetaminophen ER: HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalDec 8, 2025
- grantBROWN UNIVERSITY — Probenecid for Alcohol Use DisorderSep 18, 2025
- recallLannett Company Inc. recall (Cls II)Sep 17, 2025
🐶 often sniffed alongside
top 8- tagApproval218 co-mentions · 109 sources
- tagSmall Molecule91 co-mentions · 91 sources
- drugMETADATE CD84 co-mentions · 42 sources
- drugMETADATE ER84 co-mentions · 42 sources
- drugHYDROCODONE BITARTRATE AND ACETAMINOPHEN74 co-mentions · 28 sources
- drugmethylphenidate hydrochloride ER42 co-mentions · 42 sources
- drugmethylphenidate ER42 co-mentions · 42 sources
- drugmethylphenidate42 co-mentions · 42 sources
comments(0)
5-min edit window · permanent after that